← Back to main


 

Education & Training

Postdoctoral Training: Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 2011-2015

PhD: Medical College of Georgia at Augusta University, Augusta, GA, 2011

BA: Minnesota State University Moorhead, Minneapolis, MN, 2006

 

 

 

Awards/ Honors

Binding Proteins Specific for LOX1 and Uses Thereof
Patent number: US2017/0304343 A1
Date of Patent: 04-08-2021
Assignee: MedImmune Ltd
Inventors: Andrew Buchanan, Cambridge (GB); Matthieu Chodorge, Cambridge (GB); Peter Cariuk, Cambridge (GB); Johanna Husmark, Macclesfield (GB); Clare Balendran, Molndal (SE); Deepesh Pandey, Baltimore, MD (US); Fumin Chang, Baltimore, MD (US); Daniel E. Berkowitz, Baltimore, MD (US); Lewis H. Romer, Baltimore, MD (US).

 

 

 

Funding

Project title: "HDAC2 is a critical regulator of vascular endothelial function”
Type:  1R56
Agency: National Institute of Health, National Heart, Lung and Blood Institute 
Period: 09/15/2019-02/28/2022
Role:  PI